Initial Boston Scientific vaginal mesh trials set to erupt in March

Boston Scientific ($BSX) goes to trial on March 10, 2014, to face the first four cases alleging that the company's transvaginal mesh implant devices harmed patients. The Worcester Business Journal reported recently that a West Virginia district judge set the date. Two of the trials involve the Massachusetts company's Pinnacle transvaginal mesh, while two others cover its Obtryx mesh device, according to the article. Reportedly, close to 6,400 lawsuits remain. Boston Scientific, C.R. Bard ($BCR), Endo Health Solutions ($ENDP), Coloplast in Denmark and Cook Medical are among makers of vaginal mesh that face thousands of lawsuits in the U.S. alone alleging that their implants harmed countless women. All are reportedly in discussions with plaintiffs focused on a settlement. Story